Cyclo Therapeutics (CYTH): Company Cash Volume

Graphic logo of Cyclo Therapeutics, Inc. (CYTH)

Cyclo Therapeutics integrates ESG standards into the synthesis of cyclodextrins, adhering to bioethics and environmental disposal. The cash balance history clearly illustrates liquidity, where the value of 0.00 characterizes this level. Cyclo Therapeutics joins forces with scientists to combat Alzheimer's and Niemann-Pick disease. The priority of orphan drug patents protects the business from price wars in the rare pathology sector.

CYTH - Cyclo Therapeutics, Inc Company Cash on Hand over the range 07/04/2022 - 04/05/2025

Metric breakdowns and analytics for Cyclo Therapeutics Inc. (CYTH)

- stock value and consensus price forecast:
- stock exchange capitalization data:
General company analysis:CYTH Cyclo Therapeutics Inc.
Brand item of Cyclo Therapeutics, Inc.

This indicator tracks the volume of the most liquid assets, determining the business's ability to fund operating activities without resorting to external loans. For Cyclo Therapeutics (CYTH), this resource is critical when conducting costly biomedical research. By analyzing the cash balance on the balance sheet, an investor can see the company's actual margin of safety. The stability of the fund is supported by the neutral status of a sector shielded from geopolitical shocks. A rational liquidity balance here minimizes credit risks without sacrificing the overall return on capital.